VIP-induced neuroprotection of the developing brain.

Abstract : Excitotoxicity is a key molecular mechanism of perinatal brain damage and is associated with cerebral palsy and long term cognitive deficits. VIP induces a potent neuroprotection against perinatal excitotoxic white matter damage. VIP does not prevent the initial appearance of white matter lesion but promotes a secondary repair with axonal regrowth. This plasticity mechanism involves an atypical VPAC2 receptor and BDNF production. Stable VIP agonists mimic VIP effects when given systemically and exhibit a large therapeutic window. Unraveling cellular and molecular targets of VIP effects against perinatal white matter lesions could provide a more general rationale to understand the neuroprotection of the developing white matter against excitotoxic insults.
Type de document :
Article dans une revue
Current Pharmaceutical Design, Bentham Science Publishers, 2011, 17 (10), pp.1036-9
Liste complète des métadonnées

Littérature citée [30 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00590464
Contributeur : Pierre Gressens <>
Soumis le : jeudi 3 mai 2012 - 07:00:17
Dernière modification le : lundi 4 juin 2018 - 10:14:02
Document(s) archivé(s) le : samedi 4 août 2012 - 02:20:15

Fichiers

Manuscript-j1_1_.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

  • HAL Id : inserm-00590464, version 1
  • PUBMED : 21524251

Collections

Citation

Sandrine Passemard, Paulina Sokolowska, Leslie Schwendimann, Pierre Gressens. VIP-induced neuroprotection of the developing brain.. Current Pharmaceutical Design, Bentham Science Publishers, 2011, 17 (10), pp.1036-9. 〈inserm-00590464〉

Partager

Métriques

Consultations de la notice

220

Téléchargements de fichiers

388